Kura Oncology, Inc.KURANASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+39.3%
5Y CAGR+33.0%
Year-over-Year Change
Research and development spending
3Y CAGR
+39.3%/yr
vs +18.7%/yr prior
5Y CAGR
+33.0%/yr
Recent acceleration
Acceleration
+20.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.2x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $251.07M | +47.7% |
| 2024 | $169.97M | +47.5% |
| 2023 | $115.23M | +24.2% |
| 2022 | $92.81M | +9.6% |
| 2021 | $84.72M | +40.3% |
| 2020 | $60.40M | +26.3% |
| 2019 | $47.83M | +2.2% |
| 2018 | $46.79M | +77.0% |
| 2017 | $26.43M | +29.5% |
| 2016 | $20.40M | - |